VIROVEK'S

BAC-TO-AAV TECHNOLOGY
FOR LARGE SCALE AAV PRODUCTION

Newest patented technology to manufacture AAV vectors harboring toxins

San Francisco, California, January 7-9, 2013

Virovek presented its newest patented technology to manufacture AAV vectors harboring toxins, the first of its kind, at the Biotech Showcase 2013 where private and small- and mid-cap biotechnology companies present their innovations to investors and bio-pharmaceutical executives.